Ariad Pharmaceuticals (ARIA)
Create an Alert
17.21
-0.57 -3.23%
NASDAQ
Jun 19, 5:00PM
BATS Real time
Currency in USD
Ariad Pharmaceuticals Free Cash Flow:
-69.60M for March 31, 2013Ariad Pharmaceuticals Historical Free Cash Flow Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -69.60M |
| Dec. 31, 2012 | -42.47M |
| Sept. 30, 2012 | -45.68M |
| June 30, 2012 | -38.92M |
| March 31, 2012 | -31.67M |
| Dec. 31, 2011 | -23.08M |
| Sept. 30, 2011 | 4.522M |
| June 30, 2011 | -18.90M |
| March 31, 2011 | -17.93M |
| Dec. 31, 2010 | -12.90M |
| Sept. 30, 2010 | -2.134M |
| June 30, 2010 | 34.08M |
| March 31, 2010 | -14.67M |
| Dec. 31, 2009 | -16.15M |
| Sept. 30, 2009 | -17.40M |
| June 30, 2009 | -10.33M |
| March 31, 2009 | -11.52M |
| Dec. 31, 2008 | -13.38M |
| Sept. 30, 2008 | -7.268M |
| June 30, 2008 | -19.96M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Free Cash Flow
Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.
According to many investors, free cash flow is the best indication of a company's ability to generate cash.
Learn More
ARIA Free Cash Flow Benchmarks
| Companies | |
|---|---|
| Array BioPharma | -22.77M |
| Infinity Pharmaceuticals | -25.59M |
| Arena Pharmaceuticals | -19.49M |
ARIA Free Cash Flow Rankings
| Overall |
63rd percentile 6147 of 16782 |
| Sector |
50th percentile 702 of 1410 in Healthcare |
| Industry |
48th percentile 232 of 454 in Biotechnology |
ARIA Free Cash Flow Range, Past 5 Years
| Minimum | -69.60M | Mar 2013 |
| Maximum | 34.09M | Jun 2010 |
| Average | -18.77M |
